Acyclovir

Product NDC: 70934-401
11-digit product format: 709340401
Labeler code: 70934
Product ID: 70934-401_af48278e-a970-fe13-e053-2a95a90adf27
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Acyclovir
Dosage form: TABLET
Route: ORAL
Labeler: Denton Pharma, Inc. DBA Northwind Pharmaceuticals
Application: ANDA210401
Marketing category: ANDA
Marketing start: 2019-06-25
Marketing end: 0000-00-00
Substance: ACYCLOVIR
Active strength: 800 mg/1
Pharmacologic classes: DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [EXT]
NDC exclude flag: No
Listing certified through: 2021-12-31
Current FDA listing: Historical FDA.report record

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
X4HES1O11F	ACYCLOVIR	59277-89-3	ACYCLOVIR

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
70934-401-35	70934040135	35 TABLET in 1 BOTTLE, PLASTIC (70934-401-35)	35 tablet	2019-06-25	0000-00-00	No	No	Current
70934-401-40	70934040140	40 TABLET in 1 BOTTLE, PLASTIC (70934-401-40)	40 tablet	2019-08-19	0000-00-00	No	No	Current